Related Experiment Video
Updated: Aug 12, 2026

14:01
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
[Analysis of TAP gene in IDDM]
1Department of Endocrinology and Metabolism, Toranomon Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 1, 1994
Summary
Transporter associated with antigen processing (TAP) is not significantly different in insulin-dependent diabetes mellitus (IDDM) patients. The study found HLA-DQ locus, not TAP, shows a primary association with IDDM.
Area of Science:
- Immunogenetics
- Molecular Biology
- Endocrinology
Context:
- The Transporter associated with antigen processing (TAP) is crucial for presenting endogenous antigens.
- TAP is encoded within the Major Histocompatibility Complex (MHC) class II region.
- Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease with known genetic components.
Purpose:
- To investigate the association of Transporter associated with antigen processing (TAP) gene polymorphism with insulin-dependent diabetes mellitus (IDDM).
- To compare TAP allele frequencies between IDDM patients and healthy controls.
- To examine linkage disequilibrium between TAP and HLA-DQ loci in relation to IDDM.
Summary:
- TAP allele frequencies did not differ significantly between 95 IDDM patients and 75 controls.
- The HLA-DQ locus demonstrated a strong association with IDDM in the studied cohort.
- Linkage disequilibrium patterns were observed between specific HLA-DQ and TAP alleles, suggesting complex genetic interactions.
Impact:
- Suggests that HLA-DQ, rather than TAP, plays a primary role in the genetic susceptibility to IDDM.
- Provides insights into the immunogenetic basis of IDDM.
- Highlights the importance of considering multiple genetic loci in autoimmune disease research.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

